NSAID reduces inflammation after cataract surgery

SEATTLE — Once-daily 0.07% bromfenac ophthalmic solution safely reduces ocular inflammation after cataract surgery, according to a poster here. “Compared to placebo, low-concentration, modified bromfenac ophthalmic solution dosed once daily effectively and safely reduced ocular inflammation associated with cataract surgery,” James A. Gow and colleagues said in a poster presented at the Association for Research in Vision and Ophthalmology annual meeting.

Full Story →